The spectrum of phenylalanine hydroxylase variants and genotype–phenotype correlation in phenylketonuria patients in Gansu, China

[1]  Yaqing Guo,et al.  Identification of phenylketonuria patient genotypes using single-gene full-length sequencing , 2022, Human genomics.

[2]  C. Yin,et al.  Identification of novel deep intronic PAH gene variants in patients diagnosed with phenylketonuria , 2021, Human mutation.

[3]  P. Gunaratne,et al.  A noncoding RNA modulator potentiates phenylalanine metabolism in mice , 2021, Science.

[4]  H. Pan,et al.  Molecular diagnosis of phenylketonuria in 157 Chinese families and the results of prenatal diagnosis in these families , 2021, Chinese medical journal.

[5]  Kaili Xie,et al.  Pregestational screening of hereditary deafness genes carriers in 10,684 normal pregnant women in Zhuzhou, China , 2021, Birth defects research.

[6]  V. Stoppioni,et al.  The Genetic Landscape and Epidemiology of Phenylketonuria. , 2020, American journal of human genetics.

[7]  R. Saxena,et al.  NGS-based expanded carrier screening for genetic disorders in North Indian population reveals unexpected results – a pilot study , 2020, BMC medical genetics.

[8]  A. Seymour,et al.  5-year retrospective analysis of patients with phenylketonuria (PKU) and hyperphenylalaninemia treated at two specialized clinics. , 2019, Molecular genetics and metabolism.

[9]  Ping Liu,et al.  Concurrent Hearing and Genetic Screening of 180,469 Neonates with Follow-up in Beijing, China. , 2019, American journal of human genetics.

[10]  Juan Liang,et al.  Phenylketonuria incidence in China between 2013 and 2017 based on data from the Chinese newborn screening information system: a descriptive study , 2019, BMJ Open.

[11]  Xu Ma,et al.  Mutation spectrum of PAH gene in phenylketonuria patients in Northwest China: identification of twenty novel variants , 2019, Metabolic Brain Disease.

[12]  Nenad Blau,et al.  Relationship between genotype, phenylalanine hydroxylase expression and in vitro activity and metabolic phenotype in phenylketonuria. , 2018, Molecular genetics and metabolism.

[13]  I. Kuznetsova,et al.  Molecular-genetic causes for the high frequency of phenylketonuria in the population from the North Caucasus , 2018, PloS one.

[14]  N. Blau,et al.  Mutation spectrum of hyperphenylalaninemia candidate genes and the genotype-phenotype correlation in the Chinese population. , 2018, Clinica chimica acta; international journal of clinical chemistry.

[15]  B. Andresen,et al.  Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5’ splice site , 2018, PLoS genetics.

[16]  Jie Dong,et al.  Newborn Screening of Genetic Mutations in Common Deafness Genes With Bloodspot-Based Gene Chip Array. , 2017, American journal of audiology.

[17]  Edward L. Huttlin,et al.  Biallelic Mutations in DNAJC12 Cause Hyperphenylalaninemia, Dystonia, and Intellectual Disability. , 2017, American journal of human genetics.

[18]  A. Munnich,et al.  An Application of NGS for Molecular Investigations in Perrault Syndrome: Study of 14 Families and Review of the Literature , 2016, Human mutation.

[19]  Jun Zhu,et al.  Molecular characterisation of phenylketonuria in a Chinese mainland population using next-generation sequencing , 2015, Scientific Reports.

[20]  M. Kabra,et al.  Splice, Insertion‐Deletion and Nonsense Mutations that Perturb the Phenylalanine Hydroxylase Transcript Cause Phenylketonuria in India , 2014, Journal of cellular biochemistry.

[21]  John J. Mitchell,et al.  Phenylalanine hydroxylase deficiency: diagnosis and management guideline , 2013, Genetics in Medicine.

[22]  V. Wiwanitkit,et al.  Prevalence of neonatal hypothyroidism and phenylketonuria in Southern Thailand: A 10-year report , 2011, Indian journal of endocrinology and metabolism.

[23]  S. Kudo,et al.  Molecular characterization of phenylketonuria and tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency in Japan , 2011, Journal of Human Genetics.

[24]  Dong Hwan Lee,et al.  Mutation analysis of PAH gene and characterization of a recurrent deletion mutation in Korean patients with phenylketonuria , 2008, Experimental & Molecular Medicine.

[25]  D. Bercovich,et al.  Genotype–phenotype correlations analysis of mutations in the phenylalanine hydroxylase (PAH) gene , 2008, Journal of Human Genetics.

[26]  C. Scriver,et al.  The PAH gene, phenylketonuria, and a paradigm shift , 2007, Human mutation.

[27]  C. Aulehla‐Scholz,et al.  Mutational spectrum in German patients with phenylalanine hydroxylase deficiency , 2003, Human mutation.

[28]  S. Cederbaum.  Phenylketonuria: an update. , 2002, Current opinion in pediatrics.

[29]  A. de la Chapelle,et al.  Phenylketonuria in a low incidence population: molecular characterisation of mutations in Finland. , 1995, Journal of medical genetics.

[30]  P. Guldberg,et al.  Molecular basis for the phenotypical diversity of phenylketonuria and related hyperphenylalaninaemias , 1993, Journal of Inherited Metabolic Disease.

[31]  C. Scriver.  Phenylketonuria--genotypes and phenotypes. , 1991, The New England journal of medicine.

[32]  N. Blau,et al.  The spectrum of phenylketonuria genotypes in the Armenian population: identification of three novel mutant PAH alleles. , 2011, Molecular genetics and metabolism.

[33]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[34]  Dong-hwan Lee,et al.  Frequency and distribution of phenylketonuric mutations in orientals , 1992, Human mutation.